News Briefs
- 11/12/2026
$30 a month? These private family medicine clinics in Ottawa aren’t planning to bill OHIP
Evan Hawes, CEO of Hawes Health, told CTV News that he has commitments from 100 U.S.-based physicians who want to come work in his family medicine clinics in Ottawa, (some, at least partially, virtually).
What makes them different? They’re not billing OHIP. Instead, patients would pay a one-time $50 registration fee and a $30 monthly fee. The three initial clinics are slated to open early next year. He also says he wants to expand them into pharmacies.
“On the monthly side, that’s going to cover everything,” he told CTV News There’s no limit on how many times you can use it. There are no additional fees that come out of nowhere or per appointment. This is literally the cheapest possible that we could make, while providing your full traditional family medicine for people. We’re talking about hundreds of thousands that could be attached to primary care with this model.”
- 11/12/2026
Pfizer will no longer sell Premarin in Canada
Pfizer is no longer selling Premarin—a hormone replacement therapy—in Canada, either in tablet or vaginal cream forms.
The conjugated estrogens tablets are indicated (among other uses) for the “relief of menopausal and postmenopausal symptoms occurring in naturally or surgically induced estrogen deficiency states including vulvar and vaginal atrophy,” according to the product monograph.
The discontinuation comes as other menopause-related therapies in Canada have experienced shortages, with the Canadian Pharmacists Association having recently updated its resource for dealing with the shortages.
A new report from Reuters noted that demand for these therapies in on the rise, especially in the United States “where prescriptions have increased following the U.S. Food and Drug Association's November 2025 removal of long-standing safety warnings from the treatments.”
- 11/11/2026
Independent clinics getting added to Medinav in Manitoba?
Manitoba wants to add more walk-in clinics to Medinav.
The portal, launched two years ago, aims to connect patients with appointments as soon as same-day or next-day even on weekends and holidays. The clinics currently part of the system are all run by the government.
CBC News reported that Health Minister Uzoma Asagwara said the province wants to add independent physician-run clinics to help Manitobans get better "access to diagnostics, to lab services and all of the reasons why somebody would choose to go to a clinic at 8 o'clock at night."
- 11/10/2026
U.S. FDA announces new warning required on GLP-1 labels

The U.S. Food and Drug Administration announced this week is going to require a warning on glucagon-like peptide-1 receptor agonists labels about a rare condition.
Specifically the regulator is informing patients and healthcare professionals of an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION). This rare problem can result in acute, painless, decreased vision in one eye and can include permanent vision loss.
“The agency is requiring application holders for all GLP-1 RA medications to add information to the Warnings and Precautions section of labeling about the potential increased risk of NAION associated with use of these medications,” reads a statement on the FDA’s website.
The FDA conducted an meta-analysis for more than 100 “clinical trials across GLP-1 RA development programs because of the small number or absence of cases of NAION observed in individual trials.”
While the number of NAION events remains small, “Overall, the results showed a NAION incidence rate of 6.4 events per 100,000 PY in patients treated with GLP-1 RAs compared to 3.8 events per 100,000 PY in comparator-treated patients,” the FDA wrote.
- 11/10/2026
The U.S. is losing its pharmacies
A total of 4,178 community pharmacies opened in the U.S. between 2022 and 2024. The problem is, 7,240 closed.
A new analysis from the Journal of the American Pharmacists Association found that net loss of 3,062 was made up primarily of chain pharmacies (2,680) rather than independent stores (382).
“Pharmacy openings and closures reflect the evolving landscape of pharmacy access and build upon current understanding of the complex issues which threaten the sustainability of community pharmacy access in the United States,” the analysis concluded.
- 11/9/2026
Contaminations in unauthorized injectable peptides and non-peptide drugs, Health Canada warns
Don't buy or use these products. A simple message from Health Canada about unauthorized injectable peptide and non-peptide drugs.
"Health Canada is warning consumers not to use or inject unauthorized peptides after lab testing found bacteria in products sold online," the department said in a warning released late last week. "Injecting contaminated products can cause serious infections, hospitalization, and in severe cases, life-threatening sepsis. The risk of infection is higher in people with a compromised immune system."